VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 32 filers reported holding VERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $244,422 | -14.6% | 17,828 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $286,139 | +106.8% | 17,828 | 0.0% | 0.00% | – |
| Q1 2023 | $138,345 | -59.9% | 17,828 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $344,972 | -9.2% | 17,828 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $380,000 | +56.4% | 17,828 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $243,000 | -42.0% | 17,828 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $419,000 | -12.0% | 17,828 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $476,000 | +54.0% | 17,828 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $309,000 | +30.9% | 17,828 | 0.0% | 0.00% | – |
| Q2 2021 | $236,000 | – | 17,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,372,428 | $26,170,041 | 3.38% |
| COMMODORE CAPITAL LP | 2,824,029 | $21,914,465 | 3.34% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,002,257 | $7,747,447 | 2.16% |
| Sofinnova Investments, Inc. | 3,467,156 | $26,905,131 | 1.72% |
| Altium Capital Management LP | 286,000 | $2,219,360 | 1.23% |
| Eversept Partners, LP | 1,788,529 | $13,878,985 | 0.97% |
| SECTORAL ASSET MANAGEMENT INC | 600,300 | $4,658,328 | 0.90% |
| Octagon Capital Advisors LP | 795,000 | $6,169,200 | 0.89% |
| Carlyle Group Inc. | 2,960,231 | $22,882,586 | 0.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,300,000 | $10,088,000 | 0.22% |